Shareholding disclosure

OSI Pharmaceuticals, Inc

Declared position

10.527%

Threshold

Crossed upwards

Timeline

Published

11.02.2010

Transaction

27.01.2010

Transfer date

27.01.2010

Voting rights breakdown

Voting rights acquired10.527%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAA2A00065

Beneficial owner

OSI Pharmaceuticals, Inc

Declared address

OSI Pharmaceuticals, Inc., Melville, NY 11747

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

OSI Pharmaceuticals, Inc

HBM Healthcare Investments AG11.02.2010TAA2A00065

Disclosure summary

OSI Pharmaceuticals, Inc disclosed a holding in HBM Healthcare Investments AG on the acquisition side, published by SIX Exchange Regulation on 11.02.2010, at 10.527% of voting rights. Notice category: Single shareholder.

Disclosed position

10.527%

Voting rights acquired

Voting rights acquired10.527%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

OSI Pharmaceuticals, Inc disclosed a holding in HBM Healthcare Investments AG, published on 11.02.2010.

Publication date11.02.2010

Transaction date27.01.2010

Transfer date27.01.2010

Issuing companyHBM Healthcare Investments AG

Beneficial ownerOSI Pharmaceuticals, Inc

Declared addressOSI Pharmaceuticals, Inc., Melville, NY 11747

CategorySingle shareholder

Voting rights acquired10.527%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAA2A00065

Source: SIX Exchange Regulation · Publication date: 11.02.2010

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open